Focus Issue: Biomarkers and Risk PredictionSoluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure
Under an Elsevier user license
open archive
Graphical abstract
Key Words
heart failure
prognosis
soluble urokinase-type plasminogen activator receptor
suPAR
Abbreviations and Acronyms
AF
atrial fibrillation
CART
classification and regression tree analysis
CHF
chronic heart failure
CRP
C-reactive protein
eGFR
estimated glomerular filtration rate
IDI
integrated discrimination increment
NRI
net reclassification index
NT-proBNP
N-terminal pro B-type natriuretic peptide
NYHA
New York Heart Association
suPAR
soluble urokinase-type plasminogen activator receptor
Cited by (0)
This work was supported by the Association for the Promotion of Research on Arteriosclerosis, Thrombosis, and Vascular Biology and the Ludwig Boltzmann Cluster for Cardiovascular Research. Dr. Koller is recipient of a DOC fellowship of the Austrian Academy of Sciences (24346).
The authors have reported that they have no relationships relevant to the contents of this paper to declare.
© 2017 by the American College of Cardiology Foundation. Published by Elsevier.